Not for distribution to United States newswire services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) — Miata Metals Corp. (CSE:MMET) (FSE: 8NQ) (OTCQB: MMETF) (“Miata” or the “Company”) is pleased to announce that it has closed its previously announced short form prospectus offering (the “Offering”) of common shares of the Company (“Common Shares”). The Company issued a total of 23,958,500 Common Shares at a price of $0.48 per share for gross proceeds of $11,500,080, inclusive of the full exercise of the over-allotment option. The Common Shares were offered by way of a short form prospectus dated December 3, 2025 (the “Prospectus”) filed with the securities regulatory authorities in each of the provinces of Canada, other then the province of Québec, and in such other jurisdictions...

HANGZHOU, China, Dec. 08, 2025 (GLOBE NEWSWIRE) — Jiuzi Holdings Inc. (NASDAQ: JZXN; the “Company” or “JZXN”),  a leading new energy vehicle (NEV) dealership group operating under the brand name “Jiuzi” in China is reporting that its board of directors has approved a reverse stock split (the “Reverse Stock Split”) of the Company’s ordinary shares, a par value of US$0.00195 each (the “Ordinary Shares”), at a ratio of 1-for-40, with a post-Reverse Stock Split par value of US$0.078. The Company is undertaking the Reverse Stock Split with the objective of meeting the minimum $1.00 per Ordinary Share bid requirement for maintaining the listing of the Ordinary Shares on The Nasdaq Capital Market. The Reverse Stock Split will be effective at 04:01 p.m. (ET) on Wednesday, December 10, 2025 (the “Record Date”) and the Ordinary Shares will...

Data Demonstrate Potent in vivo Gene Editing of Hematopoietic Stem Cells (HSCs) in the Bone Marrow with Systemic Delivery in Preclinical Murine Models Using Fusogen Technology  Broadens Application of Fusogen Technology Beyond T Cells to Second Cell Type, HSCs, Showing Potent and Specific in vivo Delivery Underscores Ability of Fusogen Technology to Deliver Diverse Payloads, including CRISPR Gene-Editing and Base-Editing Machinery Highlights Potential of Fusogen Platform in Diseases like Sickle Cell Disease and Beta Thalassemia Without the Need for Conditioning Chemotherapy Sana is Incorporating its Fusogen Technology to Develop SG293, a CD8-targeted Fusosome that Makes CD19-directed CAR T Cells in vivo; Expects to File IND for SG293 in B-cell Cancers and/or B-cell Mediated Autoimmune Diseases as Early as 2027 SEATTLE, Dec. 08, 2025...

Ra’anana, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announces that it has successfully completed a pre-submission meeting with the U.S. Food and Drug Administration (FDA) regarding its PL-14 Allergy Blocker product, a novel nasal spray designed to provide protective intranasal barrier functionality. During the meeting, Polyrizon presented the general development program plan for PL-14, including the proposed manufacturing process, analytical and quality controls, and the structure of the stability program that will support future regulatory submissions. The Company also reviewed its planned biocompatibility assessment package and additional preclinical studies aligned with the FDA’s “Guidance...

RAPID CITY, S.D., Dec. 08, 2025 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that its Arkansas natural gas utility has filed a rate review application with the Arkansas Public Service Commission requesting $29.4 million in new annual revenue to recover the necessary capital infrastructure and operational costs required to deliver safe, reliable natural gas service for over 189,000 Arkansas customers in more than 100 communities in Arkansas. The company is seeking recovery of approximately $147 million in safety, reliability and system integrity investments for its natural gas pipeline infrastructure since its last general rate filing in 2023. These critical investments are required to meet system growth, ensure the safe and reliable delivery of natural gas to customers’ homes and businesses, and meet compliance...

ROAD TOWN, British Virgin Islands, Dec. 08, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (NASDAQ: AUGO) (B3: AURA33) (“Aura” or the “Company”) announces a qualitative updated to its coming years growth outlook, incorporating the recently released of the Feasibility Study for the Era Dorada Project and the successful acquisition of MSG. With the integration of these high-quality assets and projects, Aura Minerals has identified potential development scenarios in which annualized gold equivalent production (GEO)1 could reach levels exceeding 600,000 ounces over next years, driven primarily by the fully ramp up of Borborema, the integration and operational turnaround of MSG, the planned construction and ramp-up of the Era Dorada and Matupá projects and the potential expansion of production capacity at some of our mines and projects,...

Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, underscoring the potential for broad oncology applications, including hematologic malignancies CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the presentation of new preclinical data on its lead cell therapy candidate, ERNA-101, at the American Society of Hematology (ASH) Annual Meeting. The data demonstrated that its proprietary cell therapy platform can rapidly and durably reprogram immunosuppressive tumor microenvironments (TMEs) into immune-active, pro-inflammatory states to combat cancer. The platform engineers induced pluripotent stem cells...

MANITOWOC, Wis., Dec. 08, 2025 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced that it will participate in Singular Research’s 19th Annual Best of the Uncovereds Conference. The conference takes place December 11, 2025. Orion Chief Executive Officer Sally Washlow will present virtually at 11:45 a.m. ET / 8:45 a.m. PT and be available for one-on-one investor meetings throughout the event. Investors seeking meetings or more information are asked to contact their Singular Research representative. About Orion Energy SystemsOrion provides energy efficiency and clean tech solutions, including LED lighting and controls, electrical vehicle (EV) charging solutions, and maintenance...

ROAD TOWN, British Virgin Islands, Dec. 08, 2025 (GLOBE NEWSWIRE) — Aura Minerals Inc. (NASDAQ: AUGO, B3: AURA33) (“Aura” or the “Company”) is pleased to announce the results of the Feasibility Study for the Era Dorada Project (“Era Dorada” or “Project”, which project was previously known as the Cerro Blanco Project) prepared in accordance with S-K 1300. Era Dorada will be an underground gold mine with anticipated production of 111 koz GEO for the first 4 years of full production with additional potential production upside. The technical report (the “Technical Report”) titled “Feasibility Study for the Era Dorada Project, located in Jutiapa, Guatemala, near the town of Asunción Mita and border with El Salvador” was prepared by Ausenco and Snowden Optiro (Brazil).In January 2025, Aura completed the acquisition of Bluestone Resources...

Harnessing 16+ years of dividend-strategy expertise in an actively managed ETF GREENWICH, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) — Gabelli Funds, LLC (“Gabelli”) today announced the launch of the Keeley Dividend ETF (“KDVD”) on the NYSE. KDVD is an actively managed ETF that seeks to generate current income and capital appreciation by investing in dividend-paying small- and mid-cap companies. The fund is managed by Chicago-based portfolio managers Thomas E. Browne, Jr., CFA and Brian P. Leonard, CFA, who have co-managed dividend strategies for over 16 years and recently joined Gabelli following the acquisition of Keeley Asset Management in May. “We believe this is a particularly compelling moment for dividend investors,” said Leonard. “Valuations in SMID-cap equities remain more attractive than their large-cap peers, while dividend...